IL2 and neuroblastoma: In another study, it was shown that low expression of CD4+/CD25+/CD127- T reg cells and high levels of IFNγ are associated with improved survival of neuroblastoma patients which are treated with anti-GD2 antibody ch14.18/CHO in combination with interleukin 2 (IL2) [190].